|
|
HIV Update 2003 (3) - MarchPublished by: Datamonitor Published: Apr. 28, 2003 - 17 Pages Table of Contents EXECUTIVE SUMMARY ANALYSIS OF KEY DEVELOPMENTS IN MARCH 2003 COMPANY HEADLINES RESEARCH AND DEVELOPMENT HEADLINES DISEASE SPECIFIC HEADLINES EMERGING MARKETS HEADLINES APPENDIX AbstractIntroductionProvides an account of all the key market events that took place during march 2003. Key events include new product launches, clinical trial data and conference findings. Key events are analyzed in the HIV market during March. Coverage includes emerging market headlines, R&D pipeline data, epidemiology and disease specific factors. Future of HIV therapy lies in simplification of drug regimens. Scope Key events are analyzed in the HIV market during March 2003. Coverage includes emerging market headlines, R&D pipeline data, epidemiology and disease specific factors Report Highlights Further clinical trial data on BMS' atazanavir Developments in the lawsuit against GSK from the US AIDS Healthcare Foundation Reasons to Purchase Stay informed of all of the important market led events taking place in the HIV market Gain insight into the likely market impact of the events that took place in March 2003 in the HIV market Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||